PHE_Scientific_ Analysis of iPSCs by G-banding

Public Health EnglandcontractContracts FinderRef tender_205196/771051SME suitablecomplete
View buyer

Estimated value

£23k

Awarded value

£23k

Awarded 21 May 2019

Suppliers

1

Lots

1

1 awarded

Published

22 May 2019

Deadline 02 May 2019

Description

Public Health England (PHE) has awarded a contract to Cell Guidance Systems to assess the chromosomal stability of human induced pluripotent stem cells (iPSCs). The service subject to this contract are: - Be able to receive, handle and process live cells that are Advisory Committee on Dangerous Pathogens (ACDP) Hazard Group 2. - Have experience handling and fixing human induced pluripotent stem cells (iPSCs) e.g. identifying colony cultures that are in the log phase of growth. - Use Colcemid for arresting cells in metaphase so that chromosomes can be separated for cytogenetic studies. - Fix the cells using potassium chloride (KCl) solution and 3:1 methanol: acetic acid. - Assess the karyology of the fixed cells by G-banding - at least 20 G-banded metaphase spreads needed for each sample. - Provide a summary of the representative karyotype, along with additional information if any karyotypic abnormalities are found.

Scope

Reference
tender_205196/771051
Total value
£23,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
21 May 2019 to 20 May 2021
CPV classifications
73111000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
02 May 2019, 11:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£23k

Award date

21 May 2019

Contract start

21 May 2019

Contract end

20 May 2021